Back to Journals » Vascular Health and Risk Management » Volume 8

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders

Total article views   Abstract views HTML views PDF downloads Totals
14,045 Dovepress* 9,011 572+ 2,986 9,583
PubMed Central* 20 4,442 2,414 4,462
Totals 9,031 5,014 5,400 14,045
*Since 25 January 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar